We are live on ! Find out more
LAB icon

Standard BioTools
LAB

144 hedge funds and large institutions have $480M invested in Standard BioTools in 2024 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 39 increasing their positions, 35 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,045% more call options, than puts

Call options by funds: $1.26M | Put options by funds: $110K

11% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 35

3% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 34

1% less funds holding

Funds holding: 145 → 144 (-1)

18.23% less ownership

Funds ownership: 91.46% → 73.23% (-18%)

33% less capital invested

Capital invested by funds: $719M → $480M (-$239M)

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
144
Holders Change
-1
Holders Change %
-0.69%
% of All Funds
2.08%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
35
Increased
39
Reduced
35
Closed
34
Calls
$1.26M
Puts
$110K
Net Calls
+$1.15M
Net Calls Change
-$1.96M

Top Buyers

1
BlackRock
BlackRock
New York
+$39.8M
2
Morgan Stanley
Morgan Stanley
New York
+$13M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$9.99M
4
State Street
State Street
Massachusetts
+$7.32M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$7.26M

Top Sellers

1
ICM
Indaba Capital Management
California
-$20M
2
Millennium Management
Millennium Management
New York
-$19.9M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$9.4M
4
Goldman Sachs
Goldman Sachs
New York
-$6.44M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$4.58M
Name Holding Trade Value Shares
Change 		Change in
Stake
AG
101
Algert Global
California
$44K +$61.4K +25,117 New
VF
102
Virtu Financial
New York
$43K +$59.2K +24,201 New
Prudential Financial
103
Prudential Financial
New Jersey
$40.5K +$55.9K +22,856 New
Osaic Holdings
104
Osaic Holdings
Arizona
$40.4K -$1.22K -500 -2%
IEFM
105
IQ EQ Fund Management
Ireland
$38.9K +$53.7K +21,972 New
Canada Life
106
Canada Life
Manitoba, Canada
$38K – – –
State of Wisconsin Investment Board
107
State of Wisconsin Investment Board
Wisconsin
$36.9K +$10.7K +4,359 +26%
X
108
Xponance
Pennsylvania
$33.9K +$46.8K +19,143 New
RJA
109
Raymond James & Associates
Florida
$32.2K – – –
TPC
110
Takeda Pharmaceutical Company
Japan
$29.2K – – –
SSA
111
Schonfeld Strategic Advisors
New York
$28.2K -$2.97M -1,213,361 -99%
Amundi
112
Amundi
France
$26.7K +$35.4K +14,497 New
QT
113
Quantbot Technologies
New York
$25.6K +$35.3K +14,455 New
H
114
HoyleCohen
California
$23K – – –
Man Group
115
Man Group
United Kingdom
$22.9K -$728K -297,691 -96%
EWA
116
Evolution Wealth Advisors
Florida
$21.6K – – –
Mariner
117
Mariner
Kansas
$21.5K -$28.1K -11,507 -49%
GSC
118
Ground Swell Capital
South Carolina
$21.3K +$29.5K +12,049 New
FCH
119
Freestone Capital Holdings
Washington
$20.2K – – –
Pictet Asset Management
120
Pictet Asset Management
Switzerland
$20.1K – – –
VPIM
121
Vanguard Personalized Indexing Management
California
$19.5K +$27K +11,033 New
CAM
122
Cresset Asset Management
Illinois
$19.2K +$26.5K +10,858 New
AB
123
Amalgamated Bank
New York
$18K +$25.5K +10,438 New
Envestnet Asset Management
124
Envestnet Asset Management
Illinois
$17.7K +$24.5K +10,025 New
Corient Private Wealth
125
Corient Private Wealth
Florida
$17.7K +$24.4K +10,000 New
3 4
5
6 7

LAB Hedge Fund Activity: Q2 2024 in Review

144 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q2 2024, worth a combined $480M — down 33% from $719M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new LAB positions and 34 closed out — a net gain of 1 holder — while 39 added to existing stakes and 35 trimmed.

The largest buyer was BlackRock, adding an estimated $39.8M. The largest seller was Indaba Capital Management, exiting entirely with an estimated $20M sold.

  • 144 institutional investors held Standard BioTools (LAB) as of Q2 2024, down from 145 in Q1 2024.
  • Funds reported $480M of Standard BioTools stock for Q2 2024, down 33% quarter-over-quarter.
  • 35 funds opened new Standard BioTools positions in Q2 2024 and 34 closed out, a net change of +1 holder.
  • The largest Standard BioTools buyer in Q2 2024 was BlackRock, an estimated $39.8M added.
  • The largest Standard BioTools seller in Q2 2024 was Indaba Capital Management, an estimated $20M sold.

Based on aggregated 13F filings for Q2 2024.